|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.5000 - 0.5000|
|52 Week Range||0.4000 - 1.1000|
|Beta (3Y Monthly)||1.43|
|PE Ratio (TTM)||8.62|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Fuse Medical, Inc., , an emerging manufacturer and distributor of medical devices for the orthopedic and spine marketplace, announced record earnings for the fiscal year ended December 31, 2018.
Fuse Medical, Inc., , , announced that OTC Markets has identified Fuse as “Penny Stock Exempt,” meaning that shares of Fuse’s common stock, par value $0.01 per share , is no longer a “Penny Stock” as defined in Rule 3a51-1, promulgated under the Securities Exchange Act of 1934, as amended.
Fuse Medical, Inc., , , a contract manufacturer and national distributor of medical devices, announced that it has been named Number 56 on the Deloitte’s 2018 Technology Fast 500TM , an annual ranking of the fastest growing North American companies in the technology, media, telecommunications, life sciences and energy tech sectors.
Fuse Medical, Inc., , , announced that it has filed its quarterly report on Form 10-Q for the third quarter ended September 30, 2018 of the Fiscal Year 2018 with the United States Securities and Exchange Commission, on Tuesday November 13, 2018.
Fuse Medical, Inc. , announced the completion of the acquisition of Palm Springs Partners, LLC d/b/a Maxim Surgical , a manufacturing company in the spinal fusion device market and full-service medical device and distribution company .